clinical development of cetuximab in metastatic colorectal cancer
Published 10 years ago • 1.9K plays • Length 6:19Download video MP4
Download video MP3
Similar videos
-
4:28
introduction: bevacizumab versus cetuximab in metastatic colorectal cancer
-
4:56
upfront bevacizumab and cetuximab compared in metastatic colorectal cancer
-
4:16
fire-3 study: cetuximab versus bevacizumab in metastatic colorectal cancer
-
13:11
treatment sequencing in metastatic colorectal cancer
-
1:06
evaluating the role of cetuximab in metastatic colorectal cancer
-
1:50
dr. benson on sequencing strategies with cetuximab in crc
-
5:27
epoc studies: preoperative cetuximab in kras wild-type colorectal cancer
-
11:41
treating unresectable metastatic colorectal cancer
-
6:01
new drugs in development for metastatic colorectal cancer
-
3:45
fire-3: cetuximab/folfiri prolongs metastatic colorectal cancer survival
-
7:20
treating metastatic colorectal cancer: case study review
-
8:41
calgb 80405 trial results in metastatic colorectal cancer
-
9:00
first- and later-line use of panitumumab in metastatic colorectal cancer
-
5:48
management of colorectal cancer metastases
-
7:32
considerations when selecting an egfr inhibitor in metastatic colorectal cancer
-
9:05
determining optimal treatments in metastatic colorectal cancer
-
3:13
side effects of targeted agents in colorectal cancer
-
0:57
dr. peeters discusses the efficacy and safety of panitumumab versus cetuximab in colorectal cancer
-
1:13
dr. lenz on breakthrough designation of encorafenib, binimetinib, and cetuximab in braf crc